compounded tirzepatide legal status 2025 Eli Lilly has filed lawsuits against compounders selling unapproved versions of its weight-loss drugs, Mounjaro and Zepbound. With the FDA reinforcing its stance, offering may carry serious risks. Are Is Compounded Tirzepatide Going Away?

Rheumatology (Oxford) 2014

Rated 5 out of 5 Anonymous (verified owner) Been on it for several months

Each release is matched with quality documentation through a documented verification path

10.1053/j.gastro.2014.02.037 86 MorrisA

According to the October 2024 multi-society guidance from the American Society of Anesthesiologists (ASA), American Gastroenterological Association (AGA), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), most patients can safely continue their GLP-1 medications before elective procedures with appropriate risk mitigation strategies